Tom Lydon Talks Biotech ETFs on CNBC’s Power Lunch
July 22nd at 11:29am by Tom Lydon
Tom Lydon talked about biotechnology exchange traded funds (ETFs) on CNBC this afternoon. Video of Tom’s segment is below:
-
Latest
- Is Bullish Sentiment a Warning Sign for Stock ETFs?
- February 10th by
- ETF Chart of the Day: VIX
- February 10th by
- Financial ETFs are Money in the Banks
- February 10th by
- What is an ETF? — The Arbitrage Mechanism
- February 10th by
- Gold ETFs and Greece: What’s Next?
- February 10th by
- What are ETFs? — The Benefits of Transparency
- February 10th by
-
Featured
- VIX ETFs Bounce on Greek Jitters as Stocks Near 2011 High
- February 10th by
- Why ETFs Could Hit $2 Trillion This Year
- February 10th by
- Muni Bond ETFs Continue March Higher
- February 9th by
- Solar ETFs Recharging with Over 50% Rally in 2012
- February 9th by
- What Rising Treasury Yields Mean for Bond ETF Investors
- February 9th by
- Lithium ETF Rebounds on Improved Demand, Economy
- February 9th by
